期刊文献+

老年2型糖尿病患者高尿酸血症的相关因素分析 被引量:16

An analysis of correlation factors of hyperuricemia in elderly patients with type 2 diabetic mellitus
原文传递
导出
摘要 目的探讨老年2型糖尿病患者高尿酸血症的临床特征。方法将256例2型糖尿病住院患者分为老年糖尿病组(老年组)168例和非老年糖尿病组(非老年组)88例并选择37例无糖尿病老年人作为对照(对照组)。分别记录年龄、性别、体重指数、糖尿病病程,检测血清尿酸及肌酐,尿尿酸及肌酐、尿pH,计算24h尿尿酸排泄总量、尿酸清除率、肌酐清除率、尿酸清除分数等,3组间进行比较。结果老年组血清尿酸水平显著高于非老年组和对照组(均为P<0.01);而肌酐清除率〔(52.8±28.5)ml/min〕低于非老年组〔(89.9±34.3)ml/min〕(P<0.01)和对照组〔(57.9±37.6)ml/min〕(P<0.05),尿pH值下降,24h尿量增加。非老年组尿酸清除率〔(7.63±4.80)ml/min〕显著高于老年组〔(4.47±3.60)ml/min〕和对照组〔(3.75±3.20)ml/min〕(P<0.01);24h尿酸排泄量显著高于老年组和对照组(均为P<0.01)。结论老年组血清尿酸水平与年龄、血清肌酐、尿酸清除率、24h尿尿酸排泄量相关,尿酸生成增多、尿酸清除能力减退及尿量减少、尿pH值减低等多种因素共同导致老年2型糖尿病患者高尿酸血症。 Objective To explore the correlation factors of hyperuricemia in elderly patients with type 2 diabetes mellitus(T2DM). Methods Two hundred and fifty-six inpatients with T2DM were divided into elderly(n= 168)and non elderly(n= 88)groups. Another 37 elderly non-DM cases were as control. The parameters of serum uric acid and creatinine, urinary uric acid, pH and creatinine, clearance rates of uric acid and creatinine(Ccr)were determined and compared among 3 groups. Results The elderly T2DM group had higher level of serum uric acid than did non-elderly T2DMand control groups(all P〈0.01), and lower Ccr[(52.8±28.5)vs(57.9±37.6)ml/min], urinary pH lower and 24 h hour urine volume higher than did control group(all P〈0.01). Non-elderly T2DM group had more urinary uric acid amount in 24 hours(P〈0.01)higher clearance rate of uric acid [ ( 7.63 ±4.80) ml/min] than did elderly T2DM group [ (4.47 ± 3.60 ) ml/min] and control group [(3.75±3.20) ml/min] (all P〈0.01). Conclusions The hyperuricemia in elderly patients with T2DM is correlated with its lower clearance rate of uric acid and urine amount in 24 hours than those in non-elderly patients with T2DM group and normal control.
出处 《中华老年医学杂志》 CAS CSCD 北大核心 2005年第10期733-735,共3页 Chinese Journal of Geriatrics
关键词 糖尿病 2型 尿酸 痛风 Diabetis Mellitus type 2 Urine acid Gout
  • 相关文献

参考文献4

二级参考文献35

  • 1[1]Jossa F,Farinaro E,Panico S,et al. J Hum Hypertens, 1994; 8 (9): 677 ~ 681
  • 2[2]Abbott RD,Brand FN,Kannel WB,et al. J Clin Epidemiol, 1988; 41 (3): 237 ~ 242
  • 3[3]Freedman DS, Williamson DF, Gunter EW, et al. Am J Epidemiol, 1995; 141 (7): 637~ 644
  • 4[4]Tykarski A. Nephron,1991;59(3):364~368
  • 5[5]Alderman MH, Cohen H, Madhavan S, et al.Hypertension, 1999; 34(1): 144~ 150
  • 6[6]Bengtsson C, Lapidus L,Stendahl C, et al. Acta Med Scand,1988; 224 (6): 549~ 555
  • 7[7]Casiglia E, Spolaore P,Ginocchio G, et al. Eur J Epidemiol, 1993; 9(6): 577~ 586
  • 8[8]Lehto S,Niskanen L, Ronnemaa T, et al.Stroke, 1998;29(3) :635~639
  • 9[9]Roch - Ramel F, Guisan B, Diezi J. Pharmcol Exp Ther, 1997;280(2) :839~845
  • 10[10]Rieder MJ,Roman RJ,Greene AS. Hypertension, 1997; 30( 1 pt 1 ): 120~ 127

共引文献263

同被引文献110

引证文献16

二级引证文献86

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部